Skip to main content
. 2020 May 24;2020:8754730. doi: 10.1155/2020/8754730

Table 1.

Characteristics of patients in studies included in meta-analysis.

Author, year Age (years) iStent generation iStent number Follow-up (months) Number of eyes Baseline IOP (mmHg) End point IOP (mmHg) Number of baseline medications Number of end point medications Reduction in IOP (mmHg) Reduction in number of medications
Buznego, 2008 [17] NR First 1 18 41 21.5 ± 6.9 16.7 ± 6.9 1.6 ± 1.7 0.4 ± 1.7 4.8 1.2
Ahmed et al., 2014 [18] 62.8 ± 12.6 First 2 18 39 22.2 ± 2.0 11.8 ± 2.1 2 ± 0 1 ± 0 10.4 1 ± 0
Fea et al., 2014 [19] 64.5 ± 10.3 Second 2 12 94 21.1 ± 1.7 13.0 ± 2.3 1 ± 0 0.09 ± 0.40 8.1 ± 2.6 0.91 ± 0.40
Voskanyan et al., 2014 [20] 66.4 ± 10.9 Second 2 12 99 22.1 ± 3.3 15.7 ± 3.7 2.21 ± 0.44 NR 6.4 1.78 ± 0.91
Donnenfeld et al., 2015 [21] 66.7 ± 10.0 First 2 36 39 20.6 ± 2.0 15.2 ± 2.1 1 ± 0 NR 5.5 ± 2.7 NR
Katz et al., 2015 [22] 68.1 ± 9.1 First 1 18 38 19.8 ± 1.3 15.6 ± 1.5 1.71 ± 0.61 0.111 ± 0.5 4.2 1.6
67.8 ± 9.3 First 2 18 41 20.1 ± 1.6 13.8 ± 1.3 1.76 ± 0.54 0.121 ± 0.394 6.3 1.64
60.9 ± 8.1 First 3 18 40 20.4 ± 1.8 12.1 ± 1.2 1.51 ± 0.69 0.079 ± 0.269 8.3 1.50
Klamann et al., 2015 [23] 61.67 ± 5.15 Second 2 6 17 (POAG) 21.19 ± 2.56 14.19 ± 1.38 2.19 ± 0.91 0.88 ± 0.62 7.0 1.31
62.76 ± 4.81 Second 2 6 15 (PEX) 23.75 ± 3.28 15.33 ± 1.07 2.33 ± 1.23 1.04 ± 0.30 8.42 1.29
Ferguson et al., 2016 [24] 80.07 ± 8.54 First 1 24 42 20.26 ± 6.00 13.62 ± 4.55 1.95 ± 1.01 1.33 ± 1.22 6.64 0.62
Lindstrom et al., 2016 [25] 65.3 ± 9.0 Second 2 18 57 19.5 ± 1.5 14.4 ± 2.1 1 ± 0 0.02 ± 0.13 5.1 0.98
Vold et al., 2016 [26] 64.5 ± 11.1 First 2 36 54 25.5 ± 2.5 14.6 ± 2.4 0 ± 0 0.21 ± 0.54 10.9 0.79
Berdahl et al., 2017 [27] 64.7 ± 9.6 Second 2 18 53 19.7 ± 1.5 12.9 ± 2.1 2 ± 0 1 ± 0 6.8 1 ± 0
Chang et al., 2017 [28] 62.8 ± 12.6 First 2 36 39 22.4 ± 2.3 14.0 ± 2.6 2 ± 0 1 ± 0 8.4 1 ± 0
Pahlitzsch et al., 2017 [29] 68.6 ± 16.4 First 2 6 20 21.3 16.0 2.45 2.5 5.3 Increase 0.05
Shiba et al., 2017 [30] 64.6 ± 10.7 First 2 6 10 22.0 ± 3.0 16.9 ± 3.6 NR NR 5.1 NR
Katz et al., 2018 [31] 68.1 ± 9.1 First 1 42 38 19.8 ± 1.3 15.0 ± 2.8 1.71 ± 0.61 0.55 ± 0.50 4.8 1.16
68.1 ± 9.1 First 2 42 41 20.1 ± 1.6 15.7 ± 1.0 1.76 ± 0.54 0.105 ± 0.307 4.4 1.66
68.1 ± 9.1 First 3 42 40 20.4 ± 1.8 14.8 ± 1.3 1.53 ± 0.69 0.08 ± 0.27 5.6 1.45
Ahmed et al., 2019 [32] 66.5 ± 9.5 First 2 12 77 19.1 ± 3.6 18.1 ± 3.7 2.7 ± 0.8 1.69 ± 1.37 1.0 1.01
Hengerer et al., 2019 [33] 71.3 ± 10.5 Second 2 36 44 25.3 ± 6.0 14.6 ± 2.0 2.98 ± 0.88 0.55 ± 0.79 10.7 2.43

PEX = pseudoexfoliation glaucoma.